Trail Making Test
- Introduced by
- Ralph Reitan
- Year
- 1958
- Type
- Clinician-administered neuropsychological test of attention and executive function
- Family
- executive function and processing speed
What does it do?
The Trail Making Test (TMT) is a simple, brief neuropsychological test developed by Reitan in 1958 that measures visuomotor processing speed, attention, and executive function.
The TMT comprises two forms: Part A, which assesses basic processing speed and visual scanning, and Part B, which assesses executive function, task-switching, and cognitive flexibility. Despite its simplicity, the TMT is highly sensitive to cognitive impairment across a wide range of neurological and psychiatric conditions and remains one of the most widely used screening tests in neuropsychology.
The intuition behind the method
The TMT works by requiring the participant to connect numbered (Part A) or alternating numbered and lettered (Part B) dots in ascending order as quickly as possible. Part A is a relatively automatic motor and perceptual task; Part B requires working memory, task-switching, and inhibition. The difference between Part B and Part A time (B-A) isolates executive dysfunction from pure processing speed. This elegant design—using complexity as a lens to separate distinct cognitive processes—explains the TMT's enduring utility.
History
The Trail Making Test was developed by Ralph Reitan in the 1950s based on earlier work by the U.S. Army (the 'Army Individual Test of General Ability'). Reitan's 1958 publication established its validity in detecting brain dysfunction. The TMT became a standard component of the Halstead-Reitan Neuropsychological Battery and is now used across the globe in clinical neuropsychology, research, and occupational health. It has been extensively translated and normed in diverse populations. The test remains largely unchanged since its original development, attesting to its robustness.
When to use it
The TMT is indicated for screening executive function and processing speed in any patient with suspected cognitive impairment, particularly those with frontal lobe or subcortical damage (e.g., stroke, TBI, Parkinson's disease, vascular dementia). It is sensitive to delirium, dementia, attention deficit disorders, and mild cognitive impairment. The TMT is NOT diagnostic alone and should be integrated with clinical assessment, imaging, and other neuropsychological tests. It is particularly useful in busy settings due to its brevity and minimal equipment needs.
Limitations and considerations
- Limited specificity — prolonged TMT performance can reflect processing speed slowing, motor impairment, visual-motor dysfunction, attention problems, or executive dysfunction; the test does not specify which.
- Vulnerable to motor and visual limitations — arthritis, tremor, vision problems, or motor slowness unrelated to cognition inflate completion times.
- Age and education effects — substantial increases in completion time with advancing age and lower education; raw scores must be converted to age-adjusted norms for interpretation.
- Practice effects — significant improvement can occur with repeated testing (typically 10–20% reduction in time), limiting utility for frequent serial monitoring.
Source conditions do not replace independent scientific review or validation by an analysis engine.
Strengths
- Simplicity and speed — takes 5–10 minutes; requires only paper and pencil; easy to administer and score.
- Excellent sensitivity to cognitive impairment — detects executive dysfunction and slowing across diverse conditions (dementia, stroke, TBI, ADHD, depression).
- Two-part design isolates distinct processes — Part A–B difference differentiates processing speed from executive function.
- Extensive normative data — published norms available across age groups, education levels, and clinical populations globally.
Applications
- Stroke recovery monitoring: A neurologist uses the TMT to track recovery of executive function and processing speed in a patient 6 weeks post-stroke. Baseline Part B-A difference was 95 seconds; at 3-month follow-up, B-A difference has improved to 60 seconds, consistent with partial cognitive recovery.
- ADHD screening in primary care: A family medicine physician administers the TMT as part of ADHD screening in a 45-year-old patient reporting difficulty with complex tasks at work. Markedly prolonged Part B time (115 seconds, age-adjusted norm 75) with only mildly prolonged Part A suggests executive dysfunction; further neuropsychological evaluation is arranged.
- Dementia staging: A geriatrician uses serial TMT scores to track cognitive decline in a patient with diagnosed Alzheimer's disease. Over 18 months, Part B time increases from 85 to 120 seconds, suggesting progressive executive dysfunction and dementia advancement.
- Traumatic brain injury rehabilitation: A rehabilitation neuropsychologist uses the TMT every 4 weeks in a patient recovering from moderate TBI. TMT improvement (from 105 seconds at week 4 to 75 seconds at week 12) documents progress in executive function and is integrated into rehabilitation planning.
How it works
How it works
The TMT is administered as two paper forms. Part A presents 25 numbered circles (1–25) randomly distributed on a page; the participant draws connecting lines between them in ascending numerical order. Part B presents 25 circles containing alternating numbers (1–13) and letters (A–L); the participant connects them in alternating sequence (1-A-2-B-3-C, etc.) while avoiding intersecting lines. The participant is instructed to work as quickly as possible without lifting the pencil. Time (in seconds) is recorded for each part, and any errors are noted. Typical administration time is 5–10 minutes.
The TMT is scored by recording the completion time in seconds for Part A and Part B separately. The standard scoring also computes the difference B-A, which isolates executive function (task-switching, cognitive flexibility) from processing speed. Cutoff times vary by age and education; published norms are widely available. For example, median completion times in non-clinical adults are typically 25–35 seconds for Part A and 50–80 seconds for Part B; values 2 standard deviations above age-adjusted norms suggest impairment.
Prolonged time on Part A (>78 seconds in age-adjusted norms) suggests slowed processing speed or visual-motor impairment. Prolonged time on Part B relative to Part A, or a large B-A difference (>60 seconds) suggests executive dysfunction, task-switching difficulty, or cognitive flexibility impairment. Performance must always be interpreted in the context of age, education, and vision/motor ability. Very slow Part A performance invalidates Part B interpretation (since Part B includes the processing speed load of Part A).
Common pitfalls
- Using raw TMT times without age-adjustment — raw scores are meaningless; always convert to age-corrected norms for clinical interpretation.
- Over-interpreting isolated TMT slowing as dementia — prolonged TMT can reflect depression, motor slowing, visual impairment, or low motivation rather than primary cognitive impairment.
- Administering Part B when Part A is severely impaired — if Part A time is extremely prolonged (>90 seconds), Part B cannot be validly interpreted.
- Failing to account for motor, visual, or visuomotor limitations — the TMT is sensitive but not specific to cognitive impairment; motor or sensory deficits must be excluded clinically.
Frequently asked questions
What should I do if a patient makes errors on the TMT?
Common errors include skipping a number or letter, or connecting dots out of sequence. If errors are few and corrected immediately, scoring typically includes only completion time. If errors are frequent (>3) or uncorrected, document them separately; frequent errors suggest attention or instruction-following problems. Some clinicians use error count as an additional outcome; consult norms in your reference population.
How do I interpret a large difference between Part B and Part A (B-A > 60 seconds)?
A B-A difference of >60 seconds suggests executive dysfunction, task-switching difficulty, or cognitive flexibility impairment. However, always verify that Part A time is normal; a large B-A difference driven by extremely slow Part A may simply reflect processing speed slowing rather than executive dysfunction. Plot both Part A and Part B against age-adjusted norms separately.
Can I use the TMT remotely or digitally?
Digital versions exist but may not be directly comparable to paper-and-pencil norms. If digital administration is necessary, document the platform and consider whether norms for that version are published. Paper-and-pencil administration in person remains the standard; vision, motor ability, and attention can be more readily observed.
What does a normal TMT but slow processing on other tests mean?
The TMT is sensitive but not comprehensive. A patient may have normal TMT but impaired performance on other measures of processing speed or executive function (e.g., Digit Symbol Substitution Test, Wisconsin Card Sorting Test). TMT is a useful screening tool; abnormal results prompt further testing, but normal results do not exclude cognitive impairment.
Related methods
Sources
Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271-276.
Open DOI referenceCopied.Sanchez-Cubillo, I., Perianez, J. A., Adrover-Roig, D., et al. (2009). Construct validity of the Trail Making Test: Role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. Journal of the International Neuropsychological Society, 15(3), 438-450.
Open DOI referenceCopied.Corrigan, J. D., & Hinkeldey, N. S. (1987). Relationships between parts A and B of the Trail Making Test. Journal of Clinical Psychology, 43(4), 402-409.
Open DOI referenceCopied.